Evidence map›Paper›PMID 24900866›Full record

ArticleACS medicinal chemistry letters2014

Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention.

Regina Lin, Hyoungsu Kim, Jiyong Hong, Qi-Jing Li

Open access · greenAbstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. The endophyticRSC advances · 2023
    Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Regina LinDepartment of Immunology, Duke University Medical Center , Durham, North Carolina 27710, United States.
Hyoungsu KimDepartment of Chemistry, Duke University , Durham, North Carolina 27708, United States.
Jiyong HongDepartment of Chemistry, Duke University , Durham, North Carolina 27708, United States ; Department of Pharmacology and Cancer Biology, Duke University Medical Center , Durham, North Carolina 27710, United States.
Qi-Jing LiDepartment of Immunology, Duke University Medical Center , Durham, North Carolina 27710, United States.
Duke University Hospital · USDuke Medical Center · USDuke University · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Regulatory mechanisms of miR-19b, a novel mediator of T cell autoimmunityR01AI091878 · NIAID · DUKE UNIVERSITY · PI LI, QIJING · 2012 to 2016
$1.8M
NCI NIH HHS P30 CA014236NIAID NIH HHS R01 AI091878
6 · The paper itself

Abstract

Subglutinol A (1) is an immunosuppressive natural product isolated from Fusarium subglutinans, an endophytic fungus from the vine Tripterygium wilfordii. We show that 1 exerts multimodal immune-suppressive effects on activated T cells in vitro: subglutinol A (1) effectively blocks T cell proliferation and survival while profoundly inhibiting pro-inflammatory IFNγ and IL-17 production by fully differentiated effector Th1 and Th17 cells. Our data further reveal that 1 may exert its anti-inflammatory effects by exacerbating mitochondrial damage in T cells. Additionally, we demonstrate that 1 significantly reduces lymphocytic infiltration into the footpad and ameliorates footpad swelling in the mouse model of Th1-driven delayed-type hypersensitivity. These results suggest the potential of 1 as a novel therapeutic for inflammatory diseases.

Indexed as

immunosuppressive agentinflammatory diseasemitochondrial dysfunctionSubglutinolT cell activation

Identifiers

PMID24900866
PMCPMC4027759
OpenAlexW2316576012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.